You have 9 free searches left this month | to do more
Showing 1 - 25 of
619 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Completed
  • Recurrent/Refractory Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Guiyang, Guizhou, China
    Guizhou Cancer Hospita
2021-12-12
Dec 12, 2021
C
Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Mitoxantrone Hydrochloride Liposome injection
  • +2 more
  • Beijing, Beijing, China
    Beijing Chaoyang Hospital, Capital Medical University
2022-01-16
Jan 16, 2022
C
Not yet recruiting
  • Advanced Pancreatic Cancer
  • Mitoxantrone Hydrochloride Liposome injection
  • (no location specified)
2021-10-19
Oct 19, 2021
C
Not yet recruiting
  • Advanced Malignant Tumor
  • Mitoxantrone Hydrochloride Liposome
  • (no location specified)
2021-10-09
Oct 9, 2021
C
Recruiting
  • Treatment-naïve
  • Peripheral T Cell Lymphoma
  • Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Dose-expansion stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
2021-07-26
Jul 26, 2021
C
Not yet recruiting
  • Advanced Solid Tumors
  • Mitoxantrone Hydrochloride Liposome injection
  • Baoding, Hebei, China
    Affiliated Hospital of Hebei University
2021-06-04
Jun 4, 2021
I
Not yet recruiting
  • Non Hodgkin Lymphoma
  • Liposomal Mitoxantrone Hydrochloride dose level 1
  • +6 more
  • (no location specified)
2022-03-17
Mar 17, 2022
C
Not yet recruiting
  • Recurrent Head and Neck Cancer
  • Metastatic Head and Neck Cancer
  • Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
  • (no location specified)
2021-05-20
May 20, 2021
C
Not yet recruiting
  • Unresectable or Metastatic Bone and Soft Tissue Sarcoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • (no location specified)
2021-05-20
May 20, 2021
C
Not yet recruiting
  • Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • Mitoxantrone Hydrochloride liposome injection
  • Cytarabine (LoDAC)
  • Guiyang, Guizhou, China
    The Affiliated Hospital of Guizhou Medical University
2021-10-19
Oct 19, 2021
N
Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Valhalla, New York
  • +1 more
2021-10-29
Oct 29, 2021
W
Active, not recruiting
  • Granulocytic Sarcoma
  • Recurrent Adult Acute Myeloid Leukemia
  • 6,8-Bis(benzylthio)octanoic Acid
  • +3 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
2022-01-03
Jan 3, 2022
C
Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Chidamide
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
2020-12-11
Dec 11, 2020
C
Active, not recruiting
  • Advanced Solid Tumor
  • Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
  • Bengbu, Anhui, China
  • +7 more
2021-10-28
Oct 28, 2021
F
Active, not recruiting
  • Acute Myeloid Leukemia
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-07-06
Jul 6, 2021
C
Recruiting
  • Platinum-resistant Ovarian Cancer
  • Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
  • Chongqing, Chongqing, China
  • +6 more
2021-05-31
May 31, 2021
C
Not yet recruiting
  • Extranodal NK/T-cell Lymphoma, Nasal Type
  • Part 1: Liposomal mitoxantrone hydrochloride and Pegaspargase
  • +2 more
  • (no location specified)
2020-08-09
Aug 9, 2020
S
Completed
  • Neuromyelitis Optica
  • +3 more
  • Mitoxantrone
  • Buffalo, New York
    Baird Multiple Sclerosis Center
2020-12-23
Dec 23, 2020
C
Recruiting
  • Advanced Gastric Carcinoma
  • Mitoxantrone Hydrochloride Liposome, intravenous injection
  • Beijing, Beijing, China
  • +8 more
2021-05-31
May 31, 2021
U
Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-02-07
Feb 7, 2022
U
Completed
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-02-23
Feb 23, 2022
T
Recruiting
  • Relapsed Adult AML
  • Venetoclax Oral Tablet
  • Dresden, Germany
  • +5 more
2021-09-06
Sep 6, 2021
C
Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • Liposome-entrapped Mitoxantrone Hydrochloride Injection
  • (no location specified)
2021-06-14
Jun 14, 2021
P
Recruiting
  • AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
  • MRD-triggered arm
  • Prophylactic Arm
  • Heidelberg, BW, Germany
    University Hospital Heidelberg Med5
2021-01-04
Jan 4, 2021
I
Completed
  • Multiple Sclerosis
  • plasmapheresis
  • Isfahan, Iran, Islamic Republic of
    Alahra hospital
2020-08-27
Aug 27, 2020